EMA under attack again over document disclosure
This article was originally published in Scrip
Despite its renewed efforts to publish more clinical trial data, the European Medicines Agency has again come under attack by the independent French drug bulletin, Prescrire, for refusing to disclose clinical trial and other information on two medicines.
You may also be interested in...
The Conservative Party's victory in the UK general election means the Brexit withdrawal deal will be able to pass. The UK will leave the EU by 31 January and enter a transition period during which medicines regulation will remain broadly unchanged.
Health ministers have called for more action on access to medicines, including a new EU work agenda, rebuilding Europe’s manufacturing capabilities, further action on pricing, and greater leeway for member states to mitigate drug shortages by restricting parallel exports.